Fundz

Attovia Announces Second Tranche Closing of $60 Million Series A Financing and Highlights Progress Building a Best-in-Class Pipeline Leveraging the Attobody™ Platform

PUBLIC · ATTOFeb 12, 2024

Amount Raised

$30 Million

Round Type

Series A

FremontBiotechnologyTherapeutics

Description

Attovia Therapeutics announced the closing of the $30 million second tranche of its previously reported $60 million Series A financing. The funding will support building immunology and inflammation pipeline, advancing lead programs into the clinic and ongoing development of the Attobody™ platform.

Quick answer

Attovia Therapeutics raised $30 Million in a Series A round, dated February 12, 2024. Attovia Therapeutics is based in Fremont, California, United States.

How much did Attovia Therapeutics raise?
Attovia Therapeutics raised $30 Million in a Series A round on February 12, 2024.
What does Attovia Therapeutics do?
Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases.
Where is Attovia Therapeutics based and how big is it?
Attovia Therapeutics is based in Fremont, California, United States. Fundz records about 53 employees.
Who are the decision-makers at Attovia Therapeutics?
Fundz holds 1 contact at Attovia Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Attovia Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Vaccinex raised $1.2M (Seed) on March 28, 2024.
  • Avalo Therapeutics raised $131M on March 27, 2024.
  • Avenzo Therapeutics raised $150M (Series A) on March 26, 2024.
  • AEON Biopharma raised $15M (Convertible Note) on March 21, 2024.
  • Nouscom raised $76M (Series C) on March 21, 2024.
  • Enliven Therapeutics raised $90M on March 21, 2024.

Who to call at Attovia Therapeutics, and when

A new round usually means Attovia Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Attovia Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Attovia Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Attovia Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Attovia Therapeutics

Location

Fremont, California, United States

About

Attovia is creating a pipeline of biotherapeutics for the treatment of immune-mediated diseases. We leverage ATTOBODY™, our proprietary biologics platform, to generate first-in-class and best-in-class bispecifics and multispecifics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Attovia Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Attovia Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Attovia Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.